Camille L. Bedrosian
Chief Medical Officer
Chief Medical Officer at Amylyx Pharmaceuticals, Inc., filing insider transactions on 2026-09-10.
Total Purchases
—
0 transactions
Total Sales
$325K
2 transactions
Companies Traded
1
2 total filings
Active Since
2026-09-10
Last: 2026-09-10
Other Reporting Insiders at Amylyx Pharmaceuticals, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-09-10 | AMLX | Sale | 2,081 | $33.09 | $69K | 278.1K | SEC ↗ |
| 2026-09-10 | AMLX | Sale | 7,947 | $32.21 | $256K | 280.1K | SEC ↗ |
Director & Co-Chief Executive Officer